Literature DB >> 2488683

Expression of mRNA for transforming growth factors-alpha and -beta and secretion of transforming growth factor-beta by renal cell carcinoma cell lines.

E R Sargent1, L G Gomella, T P Wade, M W Ewing, A Kasid, W M Linehan.   

Abstract

Transforming growth factors (TGFs)-alpha and -beta are regulatory polypeptides that reversibly confer a transformed phenotype upon normal cultured fibroblasts. TGF-alpha is synthesized primarily by malignant cells and shares many properties with the tissue mitogen, epidermal growth factor (EGF). The expression of TGF-beta mRNA has been demonstrated in a variety of normal and malignant cell types, some of which secrete the mature protein in an inactive form. To investigate the role of TGFs in human renal cell carcinoma (RCC), we used two renal tumor-derived cell lines and one established RCC cell line for analysis of TGF-alpha and TGF-beta mRNA production and for evaluation of TGF-beta protein secretion. By northern blot hybridization, all three RCC cell lines expressed TGF-alpha and -beta mRNA. In addition, TGF-beta activity was found in the conditioned medium from these cells. The secreted TGF-beta protein, however, displayed biological activity only after activation by acid-treatment. These data demonstrate the constitutive expression of TGF-alpha and -beta mRNA by RCC cell lines and, also, the secretion by this tumor of endogenous TGF-beta protein in a latent form.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2488683     DOI: 10.3727/095535489820874904

Source DB:  PubMed          Journal:  Cancer Commun        ISSN: 0955-3541


  2 in total

1.  The role of Foxp3 and Tbet co-expressing Treg cells in lung carcinoma.

Authors:  Katerina Kachler; Corinna Holzinger; Denis I Trufa; Horia Sirbu; Susetta Finotto
Journal:  Oncoimmunology       Date:  2018-04-25       Impact factor: 8.110

2.  Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma.

Authors:  Sara García-Alonso; Inés Romero-Pérez; Lucía Gandullo-Sánchez; Luis Chinchilla; Alberto Ocaña; Juan Carlos Montero; Atanasio Pandiella
Journal:  J Exp Clin Cancer Res       Date:  2021-08-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.